Outcomes of inflammatory bowel disease in patients with eosinophil-predominant colonic inflammation

Tarik Alhmoud, Anas Gremida, DIego Colom Steele, Imaneh Fallahi, Wael Tuqan, Nina Nandy, Mahmoud Ismail, Barakat Aburajab Altamimi, Meng Jun Xiong, Audra Kerwin, David Martin

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Background Inflammatory bowel disease (IBD) is characterised by acute intestinal mucosal inflammation with chronic inflammatory features. Various degrees of mucosal eosinophilia are present along with the typical acute (neutrophil-predominant) inflammation. The effect of intestinal eosinophils on IBD outcomes remains unclear. Methods This is a retrospective study. Archived intestinal mucosal biopsy specimens of treatment-naïve IBD patients were examined by two pathologists. The number of eosinophils per high-power field was counted, and the mucosal inflammation was classified according to the eosinophilic inflammatory patterns. Clinical outcomes during the follow-up period were recorded. Results 142 treatment-naïve IBD patients were included. Mean age was 39 years. 83% of patients had ulcerative colitis, and median follow-up was 3 years. 41% of patients had disease flare(s) and 24% required hospitalisation. Eosinophil count was not associated with risk of disease flare or hospitalisation. Patients with neutrophil-predominant inflammation (>70% neutrophils) had greater risk of disease flare(s): 27(55%) versus 24(36%) and 7(28%) in patients with mixed and eosinophil-predominant inflammation, respectively (p=0.04). Overall, patients with neutrophil-predominant inflammation were more likely to have a disease flare; HR: 2.49, 95% CI (1.0 to 5.6). Hospitalisation rate was higher in patients with neutrophil-predominant inflammation: 17(35%) compared to 17(19%) in patients with eosinophil-rich inflammation (p=0.04). Kaplan-Meier analysis showed higher flare-free survival in patients with eosinophil-predominant inflammation compared to mixed and neutrophil-predominant inflammation. Conclusion IBD patients with eosinophil-predominant inflammation phenotype might have reduced risk of disease flares and hospitalisation. Larger prospective studies to assess IBD outcomes in this subpopulation are warranted.

Original languageEnglish
Article numbere000373
JournalBMJ Open Gastroenterology
Issue number1
StatePublished - Feb 16 2020


  • IBD clinical
  • crohn's colitis
  • inflammatory bowel disease
  • mucosal immunology
  • ulcerative colitis


Dive into the research topics of 'Outcomes of inflammatory bowel disease in patients with eosinophil-predominant colonic inflammation'. Together they form a unique fingerprint.

Cite this